
4-IPP
CAS No. 41270-96-6
4-IPP( 4-Iodo-6-phenylpyrimidine )
Catalog No. M21584 CAS No. 41270-96-6
4-IPP is an irreversible?inhibitor of macrophage migration inhibitory factor (MIF).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 87 | Get Quote |
![]() ![]() |
10MG | 147 | Get Quote |
![]() ![]() |
25MG | 248 | Get Quote |
![]() ![]() |
50MG | 357 | Get Quote |
![]() ![]() |
100MG | 529 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product Name4-IPP
-
NoteResearch use only, not for human use.
-
Brief Description4-IPP is an irreversible?inhibitor of macrophage migration inhibitory factor (MIF).
-
Description4-IPP is an irreversible?inhibitor of macrophage migration inhibitory factor (MIF).
-
In VitroCell Cytotoxicity Assay Cell Line:BMMs Concentration:0.5 μM, 1 μM, 2.5 μM, 5 μM, 10 μM, 25 μM, 50 μM, 100 μM, 200 μM Incubation Time:24 hours, 72 hours Result:Inhibited osteoclastogenesis in a dose-dependent manner.Western Blot Analysis Cell Line:BMMs Concentration:5 μM,10 μM, 20 μM Incubation Time:1 day, 3 days, 5 days Result:Inhibited RANKL-induced osteoclast differentiation and bone resorption.
-
In VivoAnimal Model:8-weeks-old C57BL/6J male mice Dosage:1 mg/kg, 5 mg/kg Administration:Intraperitoneal injection; every 2 days; for 8 weeks Result:Alleviated OVX-induced osteoporosis.
-
Synonyms4-Iodo-6-phenylpyrimidine
-
PathwayOthers
-
TargetOther Targets
-
RecptorMIF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number41270-96-6
-
Formula Weight282.08
-
Molecular FormulaC10H7IN2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (354.51 mM)
-
SMILESIc1cc(ncn1)-c1ccccc1
-
Chemical Name4-Iodo-6-phenyl-pyrimidine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zheng L et al. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway. FASEB J. 2019 Jun;33(6):7667-7683.
molnova catalog



related products
-
Oleclumab
Oleclumab (MEDI9447) is a human anti-CD73 monoclonal antibody with anticancer activity that inhibits the extracellular enzyme CD73 nucleic acid exonuclease activity, inhibits the adenosine pathway, and can be used for the study of metastatic desmoplasia-resistant prostate cancer.
-
DATPT
DATPT is a small molecule 12WLVSKF17 peptide mimetic molecule.DATPT inhibits SNX9-p47phox interactions and inhibits the production of reactive oxygen species and inflammatory cytokines.
-
Celosin I
Celosin H, celosin I, and celosin J could be used as chemical markers for the quality control of C. argentea seeds.